Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion

Acta Ophthalmologica

Volumn 91, Issue 4, 2013, Pages 318-324

  Higashiyama, Tomoaki ^a   Sawada, Osamu ^a   Kakinoki, Masashi ^a   Sawada, Tomoko ^a   Kawamura, Hajime ^a   Ohji, Masahito ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

bevacizumab; branch retinal vein occlusion; intravitreal injection; macular oedema; triamcinolone acetonide

Indexed keywords

BEVACIZUMAB; LEVOFLOXACIN; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ADULT; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA EDEMA; REVIEW; TRABECULOTOMY; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS HEMORRHAGE;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84878468405     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02298.x     Document Type: Review

References (28)

1. Battaglia Parodi M, Saviano S, Bergamini L, &, Ravalico G, (1999a): Grid laser treatment of macular edema in macular branch retinal vein occlusion. Doc Ophthalmol 97: 427-431.
2. Battaglia Parodi M, Saviano S, &, Ravalico G, (1999b): Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 237: 1024-1027.
3. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB III, &, Miller M, (2003): Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110: 681-686.
4. Benz MS, Murray TG, Dobovy SR, Katz RS, &, Eifrig CW, (2003): Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 121: 271-273.
5. Branch Vein Occlusion Study Group (1984): Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98: 271-282.
6. Byun YJ, Roh MI, Lee SC, &, Koh HJ, (2010): Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion. Graefes Arch Exp Ophthalmol 248: 963-971.
7. Cahill MT, Kaiser PK, Sears JE, &, Fekrat S, (2003): The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 87: 1329-1332.
8. Cakir M, Dogan M, Bayraktar Z, Bayraktar S, Acar N, Altan T, Kapran Z, &, Yilmaz OF, (2008): Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Retina 28: 465-472.
9. Campochiaro PA, Heier JS, Feiner L, et al., (2010): Ranibizumab for macular edema following branch retinal vein occlusion six-month primary end point results of a phase iii study. Ophthalmology 117: 1102-1112.
10. Çekiç O, Chang S, Tseng JJ, Barile GR, Del Priore LV, Weissman H, Schiff WM, &, Ober MD, (2005): Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 25: 851-855.
11. Çekiç O, Çakbox drawings light down and leftr M, Yazbox drawings light down and leftcbox drawings light down and left AT, Alagöz N, Bozkurt E, &, Faruk Ybox drawings light down and leftlmaz Ö, (2010): A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Curr Eye Res 35: 925-929.
12. Cheng KC, &, Wu WC, (2006): Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion. Kaohsiung J Med Sci 22: 321-330.
13. Cheng KC, Wu WC, &, Chen KJ, (2009): Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion. Eye 23: 2023-2033.
14. David R, Zangwill L, Badarna M, &, Yassur Y, (1988): Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica 197: 69-74.
15. Diago T, McCannel CA, Bakri SJ, Pulido JS, Edwards AO, &, Pach JM, (2009): Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina 29: 601-605.
16. Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS, Hollands H, &, Sharma S, (2008): Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 28: 1395-1399.
17. Guthoff R, Meigan T, Hennemann K, &, Schrader W, (2010): Comparison of bevacizumab and triamconolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis. Ophthalmologica 224: 319-324.
18. Jaissle GB, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt KU, &, Szurman P, (2009): One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 247: 27-33.
19. Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, &, Degenring RF, (2005a): Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 19: 65-71.
20. Klein R, Klein BE, Moss SE, &, Meuer SM, (2000): The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98: 133-141.
21. Kondo M, Kondo N, Ito Y, et al., (2009): Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12 months and multiple regression analysis. Retina 29: 1242-1248.
22. Krohne TU, Eter N, Holz FG, &, Meyer CH, (2008): Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol 146: 508-512.
23. Opremcak EM, &, Bruce RA, (1999): Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 19: 1-5.
24. Prager F, Michels S, Kriechbaum K, Georgopoulos M, Funk M, Geitzenauer W, Polak K, &, Schmidt-Erfurth U, (2009): Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 93: 452-456.
25. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, &, Avery RL, (2007): Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 27: 419-425.
26. Roth DB, Chich J, Spiru MJ, Green SN, Yarian DL, &, Chaudhry NA, (2003): Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 121: 1279-1282.
27. Scott IU, Ip MS, VanVeldhuisen PC, et al., (2009): A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 127: 1115-1128.
28. Tachi N, Hashimoto Y, &, Ogino N, (1999): Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 97: 465-469.